Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$133.54
-2.41%
Mkt Cap $8.72B
Analyst Ratings
Buy
12
Hold
1
Sell
0
Price Target (18 analysts)
$123.25
Range $110.00 – $145.00
Implied Upside
-7.7%
Consensus $123.25 vs current $133.54